Micro Emerging Active

VR Adviser compra Spyre Therapeutics

New narrative with limited coverage — still forming.

Pontuação
0,2
Velocidade
▲ 0,0
Artigos
2
Fontes
1

Top Movers

TickerSetorVariação
SYRE
Healthcare+61,1%

Sentiment Timeline

Desempenho por Setor

Stock Performance

Event Timeline

Abr 08, 2026
Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 … Neutral
Mar 19, 2026
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools Neutral

Artigos Relacionados

Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools

Nasdaq · Mar 19, 2026

Cronologia

Primeira detecçãoMar 19, 2026
Última atualizaçãoMar 19, 2026